These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28799854)

  • 41. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
    Otake K; Kamiguchi H; Hirozane Y
    BMC Med Genomics; 2019 Jan; 12(1):7. PubMed ID: 30630471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.
    Lind AL; Wu D; Freyhult E; Bodolea C; Ekegren T; Larsson A; Gustafsson MG; Katila L; Bergquist J; Gordh T; Landegren U; Kamali-Moghaddam M
    PLoS One; 2016; 11(2):e0149821. PubMed ID: 26914813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.
    Sharma A; Varghese AM; Vijaylakshmi K; Sumitha R; Prasanna VK; Shruthi S; Chandrasekhar Sagar BK; Datta KK; Gowda H; Nalini A; Alladi PA; Christopher R; Sathyaprabha TN; Raju TR; Srinivas Bharath MM
    Neurochem Res; 2016 May; 41(5):965-84. PubMed ID: 26646005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Joilin G; Gray E; Thompson AG; Talbot K; Leigh PN; Newbury SF; Turner MR; Hafezparast M
    Ann Med; 2022 Dec; 54(1):3069-3078. PubMed ID: 36314539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid cytotoxicity does not affect survival in amyotrophic lateral sclerosis.
    Galán L; Matías-Guiu J; Matias-Guiu JA; Yáñez M; Pytel V; Guerrero-Sola A; Vela-Souto A; Arranz-Tagarro JA; Gómez-Pinedo U; García AG
    Acta Neurol Scand; 2017 Sep; 136(3):212-216. PubMed ID: 28032330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
    Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H
    J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
    Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
    Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry.
    Ramström M; Ivonin I; Johansson A; Askmark H; Markides KE; Zubarev R; Håkansson P; Aquilonius SM; Bergquist J
    Proteomics; 2004 Dec; 4(12):4010-8. PubMed ID: 15540204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cerebrospinal fluid values of advanced oxidation protein products and total thiol content in patients with amyotrophic lateral sclerosis.
    Djordjevic G; Ljubisavljevic S; Sretenovic S; Kocic G; Stojanovic I; Stojanovic S
    Clin Neurol Neurosurg; 2017 Dec; 163():33-38. PubMed ID: 29055222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.
    Ryberg H; An J; Darko S; Lustgarten JL; Jaffa M; Gopalakrishnan V; Lacomis D; Cudkowicz M; Bowser R
    Muscle Nerve; 2010 Jul; 42(1):104-11. PubMed ID: 20583124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomics-based technologies in the discovery of biomarkers for multiple sclerosis in the cerebrospinal fluid.
    Lourenço AS; Baldeiras I; Grãos M; Duarte CB
    Curr Mol Med; 2011 Jun; 11(4):326-49. PubMed ID: 21506919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H
    Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.